115 related articles for article (PubMed ID: 38293827)
1. Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells.
Dash SR; Das C; Das B; Jena AB; Paul S; Sinha S; Tripathy J; Kundu CN
Nanomedicine (Lond); 2024 Mar; 19(7):581-596. PubMed ID: 38293827
[No Abstract] [Full Text] [Related]
2. Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β.
Dash SR; Das B; Das C; Sinha S; Paul S; Pradhan R; Kundu CN
Nanomedicine (Lond); 2023 Jan; 18(1):19-33. PubMed ID: 36916388
[TBL] [Abstract][Full Text] [Related]
3. NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells.
Dash SR; Chatterjee S; Sinha S; Das B; Paul S; Pradhan R; Sethy C; Panda R; Tripathy J; Kundu CN
Nanomedicine; 2022 Feb; 40():102502. PubMed ID: 34843984
[TBL] [Abstract][Full Text] [Related]
4. Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells.
Hembram KC; Dash SR; Das B; Sethy C; Chatterjee S; Bindhani BK; Kundu CN
Mol Pharm; 2020 Jul; 17(7):2463-2472. PubMed ID: 32407635
[TBL] [Abstract][Full Text] [Related]
5. Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner.
Satapathy SR; Nayak A; Siddharth S; Das S; Nayak D; Kundu CN
Nanomedicine; 2018 Apr; 14(3):883-896. PubMed ID: 29366881
[TBL] [Abstract][Full Text] [Related]
6. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300.
Das C; Dash SR; Sinha S; Paul S; Das B; Bhal S; Sethy C; Kundu CN
Med Oncol; 2023 Nov; 40(12):351. PubMed ID: 37940725
[TBL] [Abstract][Full Text] [Related]
7. Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer.
Hembram KC; Chatterjee S; Sethy C; Nayak D; Pradhan R; Molla S; Bindhani BK; Kundu CN
Mol Pharm; 2019 Jul; 16(7):3011-3023. PubMed ID: 31145852
[TBL] [Abstract][Full Text] [Related]
8. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
Ammanamanchi S; Brattain MG
J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
[TBL] [Abstract][Full Text] [Related]
9. Effect of melatonin on neuronal differentiation requires CBP/p300-mediated acetylation of histone H3 lysine 14.
Li X; Chen X; Zhou W; Ji S; Li X; Li G; Liu G; Wang F; Hao A
Neuroscience; 2017 Nov; 364():45-59. PubMed ID: 28782640
[TBL] [Abstract][Full Text] [Related]
10. p300 Acetyltransferase Is a Cytoplasm-to-Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β-Stimulated Hepatic Stellate Cells.
Wang Y; Tu K; Liu D; Guo L; Chen Y; Li Q; Maiers JL; Liu Z; Shah VH; Dou C; Tschumperlin D; Voneschen L; Yang R; Kang N
Hepatology; 2019 Oct; 70(4):1409-1423. PubMed ID: 31004519
[TBL] [Abstract][Full Text] [Related]
11. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer.
Waddell A; Mahmud I; Ding H; Huo Z; Liao D
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199844
[TBL] [Abstract][Full Text] [Related]
13. p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis.
Ghosh AK; Bhattacharyya S; Lafyatis R; Farina G; Yu J; Thimmapaya B; Wei J; Varga J
J Invest Dermatol; 2013 May; 133(5):1302-10. PubMed ID: 23303459
[TBL] [Abstract][Full Text] [Related]
14. Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.
Chung HH; Sze SK; Tay AS; Lin VC
J Biol Chem; 2014 Jan; 289(4):2180-94. PubMed ID: 24302725
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
[TBL] [Abstract][Full Text] [Related]
16. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation.
DiRenzo J; Shang Y; Phelan M; Sif S; Myers M; Kingston R; Brown M
Mol Cell Biol; 2000 Oct; 20(20):7541-9. PubMed ID: 11003650
[TBL] [Abstract][Full Text] [Related]
17. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
18. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
Zhao D; Mo Y; Li MT; Zou SW; Cheng ZL; Sun YP; Xiong Y; Guan KL; Lei QY
J Clin Invest; 2014 Dec; 124(12):5453-65. PubMed ID: 25384215
[TBL] [Abstract][Full Text] [Related]
19. Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development.
Lee JH; Yang B; Lindahl AJ; Damaschke N; Boersma MD; Huang W; Corey E; Jarrard DF; Denu JM
ACS Chem Biol; 2017 Nov; 12(11):2804-2814. PubMed ID: 28949514
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator.
Ghosh AK; Bhattacharyya S; Wei J; Kim S; Barak Y; Mori Y; Varga J
FASEB J; 2009 Sep; 23(9):2968-77. PubMed ID: 19395477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
